Opens in a new tab

Breaking news

Apple’s Foundation Models Redefine Mobile Functionality on iOS 26

Introduction

At WWDC 2025, Apple unveiled its groundbreaking Foundation Models framework, a move that grants developers direct access to local AI models. This innovation not only eliminates inference costs but also integrates sophisticated capabilities such as guided generation and tool calling right into mobile applications.

Empowering Developers With Local AI

With the rollout of iOS 26, a host of applications are now enhanced by Apple’s compact yet powerful AI models. While these models are smaller in scale compared to those from industry heavyweights like OpenAI, Anthropic, Google, or Meta, they provide a significant quality-of-life boost. Rather than overhauling traditional workflows, they offer subtle enhancements that streamline and personalize the user experience.

Leading the Charge: Innovative Apps

Lil Artist

Designed to foster creativity in children, the Lil Artist app introduces an AI-driven story creator. Users select a character and theme, and the app crafts a narrative on the fly—all powered by Apple’s local AI models. This seamless integration not only enriches the learning process but also encourages imaginative play.

Daylish

Daylish, a daily planner and alarm application, is experimenting with automated emoji suggestions for timeline events. By leveraging the local AI framework, the app determines relevant emojis based on event titles, refining the way users interact with their schedules.

MoneyCoach

This finance tracking application employs local models to deliver insights on spending habits. MoneyCoach highlights discrepancies, such as an above-average grocery spend for a given week, and offers categorization assistance for rapid data entry. Such features exemplify how AI can translate data into tangible financial advice.

Lookup

The word-learning app, Lookup, has incorporated two new modes using Apple’s AI. One mode generates contextual examples for a given word, while another challenges users to describe usage in a sentence. Additionally, an on-device model crafts an interactive map that traces a word’s origin, bringing etymology to life.

Tasks App

The Tasks app uses local models to suggest appropriate tags and detect recurring tasks. Furthermore, its voice recognition feature intelligently parses spoken input into distinct tasks without any internet dependency. This evolution significantly enhances user productivity in a streamlined manner.

Day One

The journaling platform Day One, owned by Automattic, now leverages Apple’s models to generate highlights, suggest titles, and propose prompts. These intelligent features not only distill key insights from entries but also encourage deeper reflection from users.

Crouton

The recipe application Crouton employs Apple’s local AI to automate tag suggestions and manage cooking timers. It even breaks down recipe instructions into clear, actionable steps. As noted by its developer on social media, the integration of Foundation Models unlocks a host of creative possibilities for enhancing the culinary experience.

Signeasy

The digital signing app Signeasy utilizes local models to extract critical details from contracts, offering users concise summaries of documents. This integration symbolizes a broader trend in which AI enhances professional tools through efficient, onsite analysis.

Conclusion

Apple’s Foundation Models framework is ushering in a new era of convenient, local AI integration. As developers continue to innovate across multiple sectors, this technology promises to refine everyday functionalities while ensuring optimal privacy and performance. The ongoing evolution of these local models highlights Apple’s commitment to blending advanced technology with seamless user experiences.

Blood Proteins May Signal Prostate Cancer Risk More Than 15 Years Before Diagnosis

Distinctive proteins in men’s blood may offer clues to prostate cancer risk more than 15 years before a diagnosis, according to research from the University of Oxford. The findings could help scientists better understand why some prostate cancers become aggressive while others grow slowly and never cause serious harm.

Researchers analyzed blood samples from 2,555 men collected between 1992 and 2000. Of those participants, 982 were later diagnosed with prostate cancer; the remaining 1,573 served as a comparison group. The team measured more than 6,000 proteins in the samples, which had been collected years—and, in some cases, more than 15 years—before diagnosis.

Protein Patterns Were Linked To Different Risks

The analysis identified proteins associated with prostate cancer risk overall, as well as proteins linked specifically to more aggressive or fast-growing forms of the disease. Higher levels of certain immune-system proteins, including GZMK and ANXA2, were associated with a lower long-term risk.

“Finding proteins linked to known prostate cancer driver genes in blood collected years before diagnosis gives us new insights into the earliest stages of the disease,” said Karl Smith-Byrne, the study’s corresponding author at Oxford.

The results, published in European Urology, are significant because prostate cancer is not a single, uniform disease. Many tumors grow slowly and may never threaten a patient’s health, while others progress rapidly and can be life-threatening. A clearer way to distinguish between these outcomes could eventually help improve how clinicians assess risk.

Promising Findings, Not A Screening Test

The researchers stressed that the protein patterns are not ready to be used as a screening test. The associations need further validation before they can inform clinical decisions, and the study does not establish that the proteins cause cancer or that measuring them can predict an individual’s outcome.

“Ultimately, we hope this will help us understand the biology of aggressive prostate cancer and identify markers that could improve how we assess risk in the future,” said first author Zhe Huang, a postdoctoral epidemiologist at Oxford Population Health.

Research Could Point To New Prevention Strategies

Prostate cancer is the most commonly diagnosed cancer among men in the European Union and the second most common worldwide, after lung cancer. In the EU, approximately 330,000 cases are diagnosed and 75,000 men die from the disease each year.

By identifying biological signals that appear long before diagnosis, the research may help scientists investigate the pathways involved in aggressive disease. Smith-Byrne said that, alongside existing and future genetic evidence, the findings could help reveal pathways that might ultimately be targeted to prevent aggressive prostate cancer.

Uol
The Future Forbes Realty Global Properties
eCredo
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter